Amendment No. 1 to Schedule TO

As filed with the Securities and Exchange Commission on February 24, 2003

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE TO-I

Amendment No. 1

Tender Offer Statement under Section 14(d)(1) or 13(e)(1)

of the Securities Exchange Act of 1934

 

 

MEDAREX, INC.

(Name of Subject Company—Issuer and Filing Person—Offeror)

 

 

OPTIONS TO PURCHASE COMMON STOCK,

par value $0.01 per share

(Title of Class of Securities)

 

 

583916-10-1

(CUSIP Number of Class of Securities)

 

 

Donald L. Drakeman

President and Chief Executive Officer

MEDAREX, INC.

707 State Road

Princeton, New Jersey 08540

Telephone: (609) 430-2880

(Name, address and telephone number of person authorized to receive

notices and communications on behalf of Filing Person)

 

 

Copies to:

W. Bradford Middlekauff

  

Nancy H. Wojtas, Esq.

Senior Vice President, General Counsel and Secretary

  

Jaimee R. King, Esq.

MEDAREX, INC.

  

COOLEY GODWARD LLP

707 State Road

  

Five Palo Alto Square, 3000 El Camino Real

Princeton, New Jersey 08540

  

Palo Alto, California 94306-2155

Telephone: (609) 430-2880

  

Telephone: (650) 843-5000

 

¨     Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

 

Check the appropriate boxes below to designate any transactions to which the statement relates:

 

¨    Third-party tender offer subject to Rule 14d-1.

 

x    Issuer tender offer subject to Rule 13e-4.

 

¨    Going-private transaction subject to Rule 13e-3.

 

¨    Amendment to Schedule 13D under Rule 13d-2.

 

Check the following box if the filing is a final amendment reporting the results of the tender offer:   ¨

 

This Amendment No. 1 to Schedule TO amends and supplements the Tender Offer Statement on Schedule TO initially filed by Medarex, Inc. (the “Company”) with the Securities and Exchange Commission on February 7, 2003, in connection with our offer to exchange all eligible options currently outstanding under the Company’s stock option plans to purchase shares of the Company’s common stock, par value $0.01 per share (“Common Stock”) held by eligible optionholders for replacement options to purchase shares of Common Stock to be granted under the Company’s stock option plans, upon the terms and subject to the conditions set forth in the Offer to Exchange, dated February 7, 2003.

 

ITEM 12.  EXHIBITS.

 

Exhibit Number

   

Description

99.(a)(1)(A)*

   

Offer to Exchange, dated February 7, 2003.

99.(a)(1)(B)*

   

Summary of Terms.

99.(a)(1)(C)*

   

Form of E-Mail Transmittal Letter.

99.(a)(1)(D)*

   

Form of Election Form.

99.(a)(1)(E)*

   

Form of Notice of Change in Election from Accept to Reject.

99.(a)(1)(F)*

   

Form of Notice of Change in Election from Reject to Accept.

99.(a)(1)(G)*

   

Memorandum to Employees Holding Eligible Employee Options.

99.(a)(1)(H)*

   

Memorandum to Executive Officers Holding Eligible Officer Options.

99.(a)(1)(I)*

   

Form of E-Mail Reminder Notice.

99.(a)(1)(J)*

   

Form of E-Mail Confirmation Notice.

99.(a)(1)(K)*

   

Form of Slide Presentation to Employees.

99.(a)(1)(L)

   

Medarex, Inc. Annual Report on Form 10-K for its fiscal year ended December 31, 2001, filed with the Securities and Exchange Commission on March 28, 2002 and incorporated herein by reference.

99.(a)(1)(M)

   

Medarex, Inc. Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 25, 2002, as amended on May 15, 2002, and incorporated herein by reference.

99.(a)(1)(N)

   

Medarex, Inc. Quarterly Report on Form 10-Q for its fiscal quarter ended September 30, 2002, filed with the Securities and Exchange Commission on November 13, 2002 and incorporated herein by reference.

99.(a)(1)(O)

   

Supplement Amending the Offer to Exchange.

99.(a)(1)(P)

   

Form of Electronic Notice to Employees of the Supplement Amending the Offer to Exchange.

99.(b)

   

Not applicable.

99(d)(1)

   

Medarex, Inc.’s 2002 New Employee Stock Option Plan (filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-8 (File No. 333-101698), filed on December 6, 2002, and incorporated herein by reference).

99(d)(2)

   

Medarex, Inc.’s 2001 Stock Option Plan (filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-8 (File No. 333-72154), filed on October 24, 2001 and incorporated herein by reference).

99(d)(3)

   

Medarex, Inc.’s 2001 Non-Director/Officer Employee Stock Option Plan (filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-8 (File No. 333-55224), filed on February 8, 2001 and incorporated herein by reference).

99(d)(4)

   

Medarex, Inc.’s 2000 Stock Option Plan (filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-8 (File No. 333-39084), filed on June 12, 2000 and incorporated herein by reference).

99(d)(5)

   

Medarex, Inc.’s 2000 Non-Director/Officer Employee Stock Option Plan (filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-8 (File No. 333-55222), filed on February 8, 2001 and incorporated herein by reference).

99(d)(6)

   

Medarex, Inc.’s 1999 Stock Option Plan (filed as Exhibit 10.85 to the Company’s Quarterly Report on Form

10-Q for its fiscal Quarter ended June 30, 1999, filed on August 13, 1999 and incorporated herein by reference).

99(d)(7)

   

Medarex, Inc.’s 1997 Stock Option Plan (filed as Exhibit 10.84 to the Company’s Quarterly Report on Form

10-Q for its fiscal Quarter ended June 30, 1999, filed on August 13, 1999 and incorporated herein by reference).

99(d)(8)

   

Medarex, Inc.’s 1996 Stock Option Plan (filed as Exhibit 4(a) to the Company’s Registration Statement on Form S-8 (File No. 333-16349), filed on November 18, 1996 and incorporated herein by reference).

 

 

Exhibit Number

   

Description

99(d)(9)

   

Medarex, Inc.’s 1995 Stock Option Plan (filed as Exhibit 10.61 to the Company’s Post-Effective Amendment No. 5 to its Registration Statement on Form S-1 (File No. 33-57366), filed on September 15, 1995 and incorporated herein by reference).

99(d)(10)

   

Medarex, Inc.’s 1994 Stock Option Plan (filed as Exhibit 4(a) to the Company’s Registration Statement on Form S-8 (File No. 80213), filed on December 8, 1995 and incorporated herein by reference).

99(d)(11)

   

Medarex, Inc.’s 1992 Stock Option Plan (filed as Exhibit 4 to the Company’s Registration Statement on Form

S-8 (File No. 33-71350), filed on November 5, 1993 and incorporated herein by reference).

99(d)(12)

   

Medarex, Inc.’s 1991 Amended and Restated Stock Option Plan (filed as Exhibit 4 to the Company’s Registration Statement on Form S-8 (File No. 33-71346), filed on November 5, 1993 and incorporated herein by reference).

99(d)(13)*

   

Form of Houston Biotechnology Incorporated 1994 Replacement Stock Option Plan.

99(d)(14)*

   

Form of Houston Biotechnology Incorporated 1994A Stock Option Plan.

99.(g)

   

Not applicable.

99.(h)

   

Not applicable.

*   Previously filed as an exhibit to the Schedule TO filed with the Securities and Exchange Commission on February 7, 2003.

 

ITEM 13.  INFORMATION REQUIRED BY SCHEDULE 13E-3.

 

Not applicable.

 

 

SIGNATURE

 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 24, 2003

 

MEDAREX, INC.

By:

  

/s/  Donald L. Drakeman        

Name:  Donald L. Drakeman

Title:    President and Chief Executive Officer

 

INDEX OF EXHIBITS

 

Exhibit Number

   

Description

99.(a)(1)(A)*

   

Offer to Exchange, dated February 7, 2003.

99.(a)(1)(B)*

   

Summary of Terms.

99.(a)(1)(C)*

   

Form of E-Mail Transmittal Letter.

99.(a)(1)(D)*

   

Form of Election Form.

99.(a)(1)(E)*

   

Form of Notice of Change in Election from Accept to Reject.

99.(a)(1)(F)*

   

Form of Notice of Change in Election from Reject to Accept.

99.(a)(1)(G)*

   

Memorandum to Employees Holding Eligible Employee Options.

99.(a)(1)(H)*

   

Memorandum to Executive Officers Holding Eligible Officer Options.

99.(a)(1)(I)*

   

Form of E-Mail Reminder Notice.

99.(a)(1)(J)*

   

Form of E-Mail Confirmation Notice.

99.(a)(1)(K)*

   

Form of Slide Presentation to Employees.

99.(a)(1)(L)

   

Medarex, Inc. Annual Report on Form 10-K for its fiscal year ended December 31, 2001, filed with the Securities and Exchange Commission on March 28, 2002 and incorporated herein by reference.

99.(a)(1)(M)

   

Medarex, Inc. Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 25, 2002, as amended on May 15, 2002, and incorporated herein by reference.

99.(a)(1)(N)

   

Medarex, Inc. Quarterly Report on Form 10-Q for its fiscal quarter ended September 30, 2002, filed with the Securities and Exchange Commission on November 13, 2002 and incorporated herein by reference.

99.(a)(1)(O)

   

Supplement Amending the Offer to Exchange.

99.(a)(1)(P)

   

Form of Electronic Notice to Employees of the Supplement Amending the Offer to Exchange.

99.(b)

   

Not applicable.

99(d)(1)

   

Medarex, Inc.’s 2002 New Employee Stock Option Plan (filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-8 (File No. 333-101698), filed on December 6, 2002, and incorporated herein by reference).

99(d)(2)

   

Medarex, Inc.’s 2001 Stock Option Plan (filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-8 (File No. 333-72154), filed on October 24, 2001 and incorporated herein by reference).

99(d)(3)

   

Medarex, Inc.’s 2001 Non-Director/Officer Employee Stock Option Plan (filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-8 (File No. 333-55224), filed on February 8, 2001 and incorporated herein by reference).

99(d)(4)

   

Medarex, Inc.’s 2000 Stock Option Plan (filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-8 (File No. 333-39084), filed on June 12, 2000 and incorporated herein by reference).

99(d)(5)

   

Medarex, Inc.’s 2000 Non-Director/Officer Employee Stock Option Plan (filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-8 (File No. 333-55222), filed on February 8, 2001 and incorporated herein by reference).

99(d)(6)

   

Medarex, Inc.’s 1999 Stock Option Plan (filed as Exhibit 10.85 to the Company’s Quarterly Report on Form

10-Q for its fiscal Quarter ended June 30, 1999, filed on August 13, 1999 and incorporated herein by reference).

99(d)(7)

   

Medarex, Inc.’s 1997 Stock Option Plan (filed as Exhibit 10.84 to the Company’s Quarterly Report on Form

10-Q for its fiscal Quarter ended June 30, 1999, filed on August 13, 1999 and incorporated herein by reference).

99(d)(8)

   

Medarex, Inc.’s 1996 Stock Option Plan (filed as Exhibit 4(a) to the Company’s Registration Statement on Form S-8 (File No. 333-16349), filed on November 18, 1996 and incorporated herein by reference).

 

Exhibit Number

   

Description

99(d)(9)

   

Medarex, Inc.’s 1995 Stock Option Plan (filed as Exhibit 10.61 to the Company’s Post-Effective Amendment No. 5 to its Registration Statement on Form S-1 (File No. 33-57366), filed on September 15, 1995 and incorporated herein by reference).

99(d)(10)

   

Medarex, Inc.’s 1994 Stock Option Plan (filed as Exhibit 4(a) to the Company’s Registration Statement on Form S-8 (File No. 80213), filed on December 8, 1995 and incorporated herein by reference).

99(d)(11)

   

Medarex, Inc.’s 1992 Stock Option Plan (filed as Exhibit 4 to the Company’s Registration Statement on Form

S-8 (File No. 33-71350), filed on November 5, 1993 and incorporated herein by reference).

99(d)(12)

   

Medarex, Inc.’s 1991 Amended and Restated Stock Option Plan (filed as Exhibit 4 to the Company’s Registration Statement on Form S-8 (File No. 33-71346), filed on November 5, 1993 and incorporated herein by reference).

99(d)(13)*

   

Form of Houston Biotechnology Incorporated 1994 Replacement Stock Option Plan.

99(d)(14)*

   

Form of Houston Biotechnology Incorporated 1994A Stock Option Plan.

99.(g)

   

Not applicable.

99.(h)

   

Not applicable.

*   Previously filed as an exhibit to the Schedule TO filed with the Securities and Exchange Commission on February 7, 2003.